We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

EON Resources (EONR) has entered into an agreement with Pogo Royaltythat would result in a restructure of EON’s balance sheet through the ...

The Royalty Agreement contemplates the closing of a second tranche of US$1,470,000, to be paid within six months, which will automatically increase the Silver Royalty to 15%. If the second tranche ...

Under a royalty monetization agreement finalized in December 2024 ... particularly not in connection with any contract or investment decision. The Company disclaims any obligation to update ...

Pascal Prigent, CEO of GENFIT, commented: “This non-dilutive financial agreement is a pivotal step in strengthening our financial outlook, extending our cash runway beyond 2027. We are also ...

Once determined, interested holders will sign bond repurchase agreements and GENFIT will convene the bondholders' meeting. If the bondholders approve the necessary amendments to the 2025 OCEANEs' ...

Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that Idorsia Pharmaceuticals has entered into a royalty monetization agreement with the R-Bridge Healthcare ...

GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases (the “Company”), today announces that it has entered into a non ...